Cancer cells hijack T-cell mitochondria
Source abstract
Abstract
Nanotube-mediated acquisition of immune cells’ mitochondria by tumour cells is a novel mechanism for immune evasion that can be pharmacologically targeted to potentiate cancer immunotherapies.
The source flagged this abstract for review. Check formulas and completeness against the original publication.
Source: openaire · Quality: needs review · Source record ↗
Source flags: short_text
Source flags: short_text
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Autophagy in Disease and Therapy · Immunotherapy and Immune Responses
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (10)
Show source-provided references
1. Saha, T. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-021-01000-4 (2021).10.1038/s41565-021-01000-4 ↗
2. Bantug, G. R. et al. Nat. Rev. Immunol. 18, 19–34 (2018).10.1038/nri.2017.99 ↗
3. Sukumar, M. et al. Cell Metab. 23, 63–76 (2016).10.1016/j.cmet.2015.11.002 ↗
4. Spees, J. L. et al. Proc. Natl Acad. Sci. USA 103, 1283–1288 (2006).10.1073/pnas.0510511103 ↗
5. Berridge, M. et al. Anal. Biochem. 552, 75–80 (2018).10.1016/j.ab.2017.11.008 ↗
6. Mohammadalipour, A. et al. Front. Cell Dev. Biol. 8, 1519 (2020).10.3389/fcell.2020.603292 ↗
7. Burt, R. et al. Blood 134, 1415–1429 (2019).10.1182/blood.2019001398 ↗
8. Moschoi, R. et al. Blood 128, 253–264 (2016).10.1182/blood-2015-07-655860 ↗
9. Yu, Y.-R. et al. Nat. Immunol. 21, 1540–1551 (2020).10.1038/s41590-020-0793-3 ↗
10. Pilipow, K. et al. JCI Insight 3, e122299 (2018).10.1172/jci.insight.122299 ↗